$CAQ Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in VIA Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in VIA Pharmaceuticals, Inc.. Get notifications about new insider transactions in VIA Pharmaceuticals, Inc. for free.

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Nov 17 2010	CAQ	VIA Pharmaceutical ...	GIVEN DOUGLAS B	Director	Option Exercise	P	0.07	12,065	857	17,104
Nov 17 2010	CAQ	VIA Pharmaceutical ...	CRAVES FRED B	Director	Option Exercise	P	0.07	60,495	4,295	85,760
Nov 17 2010	CAQ	VIA Pharmaceutical ...	CRAVES FRED B	Director	Option Exercise	P	0.07	3,671,806	260,698	5,205,325
Nov 16 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.07	29,985	2,129	101,646
Nov 16 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.07	1,654,479	117,468	5,608,468
Nov 16 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.07	149,927	10,645	508,234
Nov 16 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.07	8,272,394	587,340	28,042,335
Nov 16 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.07	891,549	63,300	3,022,236
Nov 16 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.07	41,361,972	2,936,700	140,211,678
Mar 30 2010	CAQ	VIA Pharmaceutical ...	CRAVES FRED B	Director	Option Exercise	P	0.17	25,265	4,295	25,265
Mar 30 2010	CAQ	VIA Pharmaceutical ...	CRAVES FRED B	Director	Option Exercise	P	0.17	1,533,519	260,698	1,533,519
Mar 30 2010	CAQ	VIA Pharmaceutical ...	GIVEN DOUGLAS B	Director	Option Exercise	P	0.17	5,039	857	5,039
Mar 30 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.17	12,253	2,083	12,253
Mar 30 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.17	690,989	117,468	690,989
Mar 30 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.17	62,617	10,645	62,617
Mar 30 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.17	3,454,941	587,340	3,454,941
Mar 30 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.17	372,353	63,300	372,353
Mar 30 2010	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.17	17,274,706	2,936,700	17,274,706
Mar 16 2009	CAQ	VIA Pharmaceutical ...	GIVEN DOUGLAS B	Director	Option Exercise	P	0.12	23,819	2,858	23,819
Mar 16 2009	CAQ	VIA Pharmaceutical ...	CRAVES FRED B	Director	Option Exercise	P	0.12	119,308	14,317	119,308
Mar 16 2009	CAQ	VIA Pharmaceutical ...	CRAVES FRED B	Director	Option Exercise	P	0.12	7,241,618	868,994	7,241,618
Mar 13 2009	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.12	59,138	7,097	59,138
Mar 13 2009	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.12	3,263,000	391,560	3,263,000
Mar 13 2009	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.12	295,690	35,483	295,690
Mar 13 2009	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.12	16,315,000	1,957,800	16,315,000
Mar 13 2009	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.12	1,758,333	211,000	1,758,333
Mar 13 2009	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Option Exercise	P	0.12	81,575,000	9,789,000	81,575,000
Dec 19 2008	CAQ	VIA Pharmaceutical ...	Taub Rebecca	SVP, Research & Dev ...	Grant	A	0.00	125,000	0	157,500	32.5 K to 157.5 K (+384.62 %)
Dec 19 2008	CAQ	VIA Pharmaceutical ...	Taub Rebecca	SVP, Research & Dev ...	Buy	P	0.30	32,500	9,750	32,500	0 to 32.5 K
Dec 19 2008	CAQ	VIA Pharmaceutical ...	Stewart James Gordon	SVP, CFO and Secret ...	Grant	A	0.00	125,000	0	217,930	92.9 K to 217.9 K (+134.51 %)
Dec 19 2008	CAQ	VIA Pharmaceutical ...	Cohen Lawrence Kenneth	CEO and President	Grant	A	0.00	300,000	0	419,660	119.7 K to 419.7 K (+250.71 %)
Dec 19 2008	CAQ	VIA Pharmaceutical ...	LARSON JOHN RANDOLPH	Director	Option Exercise	A	0.15	10,000	1,500	10,000
Dec 19 2008	CAQ	VIA Pharmaceutical ...	HOWARD DAVID T	Director	Option Exercise	A	0.15	10,000	1,500	10,000
Dec 19 2008	CAQ	VIA Pharmaceutical ...	Bagnall Mark	Director	Option Exercise	A	0.15	10,000	1,500	10,000
Dec 19 2008	CAQ	VIA Pharmaceutical ...	ANDERSON RICHARD L	Director	Option Exercise	A	0.15	10,000	1,500	10,000
Jan 16 2008	CAQ	VIA Pharmaceutical ...	Taub Rebecca	SVP, Research & Dev ...	Option Exercise	A	2.90	235,000	681,500	235,000
Dec 19 2007	CAQ	VIA Pharmaceutical ...	Stewart James Gordon	SVP, CFO and Secret ...	Option Exercise	A	2.38	310,000	737,800	310,000
Dec 19 2007	CAQ	VIA Pharmaceutical ...	OLUKOTUN ADEOYE Y	Chief Medical Offic ...	Option Exercise	A	2.38	120,000	285,600	120,000
Dec 19 2007	CAQ	VIA Pharmaceutical ...	LARSON JOHN RANDOLPH	Director	Option Exercise	A	2.38	20,000	47,600	20,000
Dec 19 2007	CAQ	VIA Pharmaceutical ...	HOWARD DAVID T	Director	Option Exercise	A	2.38	20,000	47,600	20,000
Dec 19 2007	CAQ	VIA Pharmaceutical ...	Cohen Lawrence Kenneth	CEO and President	Option Exercise	A	2.38	600,000	1,428,000	600,000
Dec 19 2007	CAQ	VIA Pharmaceutical ...	Bagnall Mark	Director	Option Exercise	A	2.38	20,000	47,600	20,000
Dec 19 2007	CAQ	VIA Pharmaceutical ...	ANDERSON RICHARD L	Director	Option Exercise	A	2.38	20,000	47,600	20,000
Nov 07 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.21	39,904	128,092	1,244,708	1.3 M to 1.2 M (-3.11 %)
Nov 07 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.38	64	216	1,284,612	1.3 M to 1.3 M (0.00 %)
Nov 07 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.21	23,234	74,581	724,779	748 K to 724.8 K (-3.11 %)
Nov 07 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.38	36	122	748,013	748 K to 748 K (0.00 %)
Nov 02 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.97	74	293	1,284,676	1.3 M to 1.3 M (-0.01 %)
Nov 02 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.97	42	167	748,049	748.1 K to 748 K (-0.01 %)
Oct 30 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.92	1,459	5,725	1,284,750	1.3 M to 1.3 M (-0.11 %)
Oct 30 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.92	848	3,327	748,091	748.9 K to 748.1 K (-0.11 %)
Oct 26 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.88	1,359	5,267	1,286,209	1.3 M to 1.3 M (-0.11 %)
Oct 26 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.91	8,322	32,576	1,287,568	1.3 M to 1.3 M (-0.64 %)
Oct 26 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.97	64	254	1,295,890	1.3 M to 1.3 M (0.00 %)
Oct 26 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.98	445	1,771	1,295,954	1.3 M to 1.3 M (-0.03 %)
Oct 26 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.88	790	3,062	748,939	749.7 K to 748.9 K (-0.11 %)
Oct 26 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.91	4,845	18,966	749,729	754.6 K to 749.7 K (-0.64 %)
Oct 26 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.97	36	143	754,574	754.6 K to 754.6 K (0.00 %)
Oct 26 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.98	259	1,031	754,610	754.9 K to 754.6 K (-0.03 %)
Oct 19 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.98	582	2,316	1,296,399	1.3 M to 1.3 M (-0.04 %)
Oct 19 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	4.03	3,430	13,807	1,296,981	1.3 M to 1.3 M (-0.26 %)
Oct 19 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	3.98	338	1,345	754,869	755.2 K to 754.9 K (-0.04 %)
Oct 19 2007	CAQ	VIA Pharmaceutical ...	Flynn James E	10% Owner	Sell	S	4.03	1,995	8,030	755,207	757.2 K to 755.2 K (-0.26 %)
Aug 10 2007	CAQ	VIA Pharmaceutical ...	ANDERSON RICHARD L	Director	Buy	P	2.43	10,000	24,300	10,000	0 to 10 K
Aug 08 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	P	2.43	2,328	5,657	7,135	4.8 K to 7.1 K (+48.43 %)
Aug 08 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	P	2.43	128,477	312,199	393,692	265.2 K to 393.7 K (+48.44 %)
Aug 08 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	P	2.43	11,642	28,290	35,676	24 K to 35.7 K (+48.44 %)
Aug 08 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	P	2.43	642,384	1,560,993	1,968,460	1.3 M to 2 M (+48.44 %)
Aug 08 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	P	2.43	69,232	168,234	212,149	142.9 K to 212.1 K (+48.44 %)
Aug 08 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	P	2.43	3,211,919	7,804,963	9,842,297	6.6 M to 9.8 M (+48.44 %)
Aug 06 2007	CAQ	VIA Pharmaceutical ...	OLUKOTUN ADEOYE Y	Chief Medical Offic ...	Option Exercise	A	3.48	40,000	139,200	95,758
Aug 06 2007	CAQ	VIA Pharmaceutical ...	Stewart James Gordon	SVP, CFO and Secret ...	Option Exercise	A	3.48	80,000	278,400	80,000
Aug 06 2007	CAQ	VIA Pharmaceutical ...	Cohen Lawrence Kenneth	CEO and President	Option Exercise	A	3.48	185,000	643,800	296,516
Jun 07 2007	CAQ	VIA Pharmaceutical ...	LARSON JOHN RANDOLPH	Director	Option Exercise	A	5.10	5,575	28,433	20,957
Jun 07 2007	CAQ	VIA Pharmaceutical ...	Stewart James Gordon	SVP, CFO and Secret ...	Grant	A	0.00	92,930	0	92,930	0 to 92.9 K
Jun 07 2007	CAQ	VIA Pharmaceutical ...	ANDERSON RICHARD L	Director	Option Exercise	A	5.10	5,575	28,433	5,575
Jun 07 2007	CAQ	VIA Pharmaceutical ...	GIVEN DOUGLAS B	Director	Grant	A	0.00	122,867	0	122,867	0 to 122.9 K
Jun 07 2007	CAQ	VIA Pharmaceutical ...	Bagnall Mark	Director	Option Exercise	A	5.10	5,575	28,433	5,575
Jun 07 2007	CAQ	VIA Pharmaceutical ...	HOWARD DAVID T	Director	Option Exercise	A	5.10	5,575	28,433	5,575
Jun 07 2007	CAQ	VIA Pharmaceutical ...	OLUKOTUN ADEOYE Y	Chief Medical Offic ...	Option Exercise	A	0.03	55,758	1,673	55,758
Jun 07 2007	CAQ	VIA Pharmaceutical ...	OLUKOTUN ADEOYE Y	Chief Medical Offic ...	Grant	A	0.00	59,624	0	59,624	0 to 59.6 K
Jun 07 2007	CAQ	VIA Pharmaceutical ...	Cohen Lawrence Kenneth	CEO and President	Option Exercise	A	0.03	111,516	3,345	111,516
Jun 07 2007	CAQ	VIA Pharmaceutical ...	Cohen Lawrence Kenneth	CEO and President	Grant	A	0.00	119,660	0	119,660	0 to 119.7 K
Jun 07 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	J	0.00	4,807	0	4,807	0 to 4.8 K
Jun 07 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	J	0.00	265,215	0	265,215	0 to 265.2 K
Jun 07 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	J	0.00	24,034	0	24,034	0 to 24 K
Jun 07 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	J	0.00	1,326,076	0	1,326,076	0 to 1.3 M
Jun 07 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	J	0.00	142,917	0	142,917	0 to 142.9 K
Jun 07 2007	CAQ	VIA Pharmaceutical ...	BAY CITY CAPITAL LLC	10% Owner	Buy	J	0.00	6,630,378	0	6,630,378	0 to 6.6 M
Jun 23 2006	CAQ	VIA Pharmaceutical ...	OTTO RICHARD E	Chief Executive Off ...	Option Exercise	A	0.75	200,000	150,000	200,000
Jun 23 2006	CAQ	VIA Pharmaceutical ...	ATWOOD ROBERT T	CFO, Executive VP	Option Exercise	A	0.75	200,000	150,000	200,000
May 15 2006	CAQ	VIA Pharmaceutical ...	Steele Michael K	VP - Business Devel ...	Option Exercise	A	0.85	60,000	51,000	60,000
May 15 2006	CAQ	VIA Pharmaceutical ...	CHIANG YAWEN L	SVP - Chief Scienti ...	Option Exercise	A	0.85	100,000	85,000	100,000
May 15 2006	CAQ	VIA Pharmaceutical ...	CALLICUTT JACK W	VP-Finance&Admin, C ...	Option Exercise	A	0.85	80,000	68,000	80,000
May 15 2006	CAQ	VIA Pharmaceutical ...	SCHMITT VICTOR W	Director	Option Exercise	A	0.85	87,769	74,604	87,769
May 15 2006	CAQ	VIA Pharmaceutical ...	NICHOL F RICHARD PHD	Director	Option Exercise	A	0.85	99,169	84,294	99,169
May 15 2006	CAQ	VIA Pharmaceutical ...	ROYSTON IVOR	Director	Option Exercise	A	0.85	87,769	74,604	87,769
May 15 2006	CAQ	VIA Pharmaceutical ...	PARSHALL B LYNNE	Director	Option Exercise	A	0.85	114,554	97,371	114,554
May 15 2006	CAQ	VIA Pharmaceutical ...	OTTO RICHARD E	Chief Executive Off ...	Option Exercise	A	0.85	200,000	170,000	200,000
May 15 2006	CAQ	VIA Pharmaceutical ...	LARSON JOHN RANDOLPH	Director	Option Exercise	A	0.85	118,261	100,522	118,261
May 15 2006	CAQ	VIA Pharmaceutical ...	GILSTRAP JAMES C	Director	Option Exercise	A	0.85	114,554	97,371	114,554
May 15 2006	CAQ	VIA Pharmaceutical ...	FALKENBERG ERIC N	Director	Option Exercise	A	0.85	118,261	100,522	118,261
May 15 2006	CAQ	VIA Pharmaceutical ...	ATWOOD ROBERT T	CFO, Executive VP	Option Exercise	A	0.85	200,000	170,000	200,000
Oct 04 2005	CAQ	VIA Pharmaceutical ...	Steele Michael K	VP - Business Devel ...	Option Exercise	A	4.45	20,000	89,000	20,000
Oct 04 2005	CAQ	VIA Pharmaceutical ...	CHIANG YAWEN L	SVP - Chief Scienti ...	Option Exercise	A	4.45	50,000	222,500	50,000
Oct 04 2005	CAQ	VIA Pharmaceutical ...	CALLICUTT JACK W	VP-Finance&Admin, C ...	Option Exercise	A	4.45	40,000	178,000	40,000
May 16 2005	CAQ	VIA Pharmaceutical ...	ROYSTON IVOR	Director	Option Exercise	A	3.98	15,000	59,670	15,000
May 16 2005	CAQ	VIA Pharmaceutical ...	SCHMITT VICTOR W	Director	Option Exercise	A	3.98	15,000	59,670	15,000
May 16 2005	CAQ	VIA Pharmaceutical ...	PARSHALL B LYNNE	Director	Option Exercise	A	3.98	18,000	71,604	18,000
May 16 2005	CAQ	VIA Pharmaceutical ...	PARSHALL B LYNNE	Director	Option Exercise	A	3.98	24,000	95,472	24,000
May 16 2005	CAQ	VIA Pharmaceutical ...	NICHOL F RICHARD PHD	Director	Option Exercise	A	3.98	18,000	71,604	18,000
May 16 2005	CAQ	VIA Pharmaceutical ...	LARSON JOHN RANDOLPH	Director	Option Exercise	A	3.98	21,000	83,538	21,000
May 16 2005	CAQ	VIA Pharmaceutical ...	GILSTRAP JAMES C	Director	Option Exercise	A	3.98	18,000	71,604	18,000
May 16 2005	CAQ	VIA Pharmaceutical ...	FALKENBERG ERIC N	Director	Option Exercise	A	3.98	21,000	83,538	21,000
May 03 2005	CAQ	VIA Pharmaceutical ...	Steele Michael K	Sr VP - Business De ...	Option Exercise	A	4.04	30,000	121,200	0
Feb 17 2005	CAQ	VIA Pharmaceutical ...	OTTO RICHARD E	Chief Executive Off ...	Option Exercise	A	5.01	10,000	50,100	10,000
Feb 17 2005	CAQ	VIA Pharmaceutical ...	ATWOOD ROBERT T	CFO, Executive VP	Option Exercise	A	5.01	10,000	50,100	10,000
Feb 08 2005	CAQ	VIA Pharmaceutical ...	OTTO RICHARD E	Chief Executive Off ...	Option Exercise	A	5.10	500,000	2,550,000	500,000
Feb 08 2005	CAQ	VIA Pharmaceutical ...	ATWOOD ROBERT T	CFO, Executive VP	Option Exercise	A	5.10	500,000	2,550,000	500,000
Jan 28 2005	CAQ	VIA Pharmaceutical ...	LARSON JOHN RANDOLPH	Director	Option Exercise	M	1.75	9,970	17,448	0
Jan 28 2005	CAQ	VIA Pharmaceutical ...	LARSON JOHN RANDOLPH	Director	Buy	M	1.75	9,970	17,448	30,762	20.8 K to 30.8 K (+47.95 %)
Jan 28 2005	CAQ	VIA Pharmaceutical ...	LARSON JOHN RANDOLPH	Director	Payment of Exercise	F	5.24	3,330	17,449	20,792	24.1 K to 20.8 K (-13.80 %)
Jan 25 2005	CAQ	VIA Pharmaceutical ...	SCHMITT VICTOR W	Director	Option Exercise	M	5.25	2,365	12,416	0
Jan 25 2005	CAQ	VIA Pharmaceutical ...	SCHMITT VICTOR W	Director	Buy	M	5.25	90	473	14,820	14.7 K to 14.8 K (+0.61 %)
Jan 24 2005	CAQ	VIA Pharmaceutical ...	ATWOOD ROBERT T	CFO, Executive VP	Option Exercise	M	1.75	39,881	69,792	0
Jan 24 2005	CAQ	VIA Pharmaceutical ...	ATWOOD ROBERT T	CFO, Executive VP	Buy	M	1.75	39,881	69,792	53,123	13.2 K to 53.1 K (+301.17 %)
Jan 24 2005	CAQ	VIA Pharmaceutical ...	ATWOOD ROBERT T	CFO, Executive VP	Payment of Exercise	F	5.19	13,447	69,790	13,242	26.7 K to 13.2 K (-50.38 %)
Jan 24 2005	CAQ	VIA Pharmaceutical ...	OTTO RICHARD E	Chief Executive Off ...	Option Exercise	M	1.75	39,881	69,792	0
Jan 24 2005	CAQ	VIA Pharmaceutical ...	OTTO RICHARD E	Chief Executive Off ...	Buy	M	1.75	39,881	69,792	57,850	18 K to 57.9 K (+221.94 %)
Jan 24 2005	CAQ	VIA Pharmaceutical ...	OTTO RICHARD E	Chief Executive Off ...	Payment of Exercise	F	5.19	13,447	69,790	17,969	31.4 K to 18 K (-42.80 %)
Sep 27 2004	CAQ	VIA Pharmaceutical ...	Russell Gayle	Sr VP - Clinical & ...	Option Exercise	A	5.27	20,000	105,400	20,000
Sep 27 2004	CAQ	VIA Pharmaceutical ...	CALLICUTT JACK W	VP-Finance&Admin, C ...	Option Exercise	A	5.25	50,000	262,500	50,000
Sep 27 2004	CAQ	VIA Pharmaceutical ...	GILSTRAP JAMES C	Director	Option Exercise	A	5.25	20,000	105,000	20,000
Sep 27 2004	CAQ	VIA Pharmaceutical ...	CHIANG YAWEN L	VP-Mfg, Chf Scienti ...	Option Exercise	A	5.25	50,000	262,500	50,000
May 11 2004	CAQ	VIA Pharmaceutical ...	OTTO RICHARD E	Chief Executive Off ...	Option Exercise	A	5.50	200,000	1,100,000	200,000
May 11 2004	CAQ	VIA Pharmaceutical ...	OTTO RICHARD E	Chief Executive Off ...	Buy	P	5.50	5,000	27,500	9,232	4.2 K to 9.2 K (+118.15 %)
May 17 2004	CAQ	VIA Pharmaceutical ...	FALKENBERG ERIC N	Director	Buy	P	5.99	12,500	74,875	12,500	0 to 12.5 K
May 17 2004	CAQ	VIA Pharmaceutical ...	FALKENBERG ERIC N	Director	Buy	P	6.09	12,500	76,125	22,500	10 K to 22.5 K (+125.00 %)
May 11 2004	CAQ	VIA Pharmaceutical ...	ATWOOD ROBERT T	CFO, Executive VP	Option Exercise	A	5.50	200,000	1,100,000	200,000
May 11 2004	CAQ	VIA Pharmaceutical ...	ATWOOD ROBERT T	CFO, Executive VP	Buy	P	5.50	5,000	27,500	24,419	19.4 K to 24.4 K (+25.75 %)
May 11 2004	CAQ	VIA Pharmaceutical ...	SCHMITT VICTOR W	Director	Option Exercise	A	5.50	15,000	82,500	15,000
May 11 2004	CAQ	VIA Pharmaceutical ...	SCHMITT VICTOR W	Director	Buy	P	5.50	10,000	55,000	14,730	4.7 K to 14.7 K (+211.42 %)
May 11 2004	CAQ	VIA Pharmaceutical ...	ROYSTON IVOR	Director	Option Exercise	A	5.50	15,000	82,500	15,000
May 11 2004	CAQ	VIA Pharmaceutical ...	ROYSTON IVOR	Director	Option Exercise	A	5.50	500	2,750	500
May 11 2004	CAQ	VIA Pharmaceutical ...	ROYSTON IVOR	Director	Buy	P	5.50	10,909	60,000	126,963	116.1 K to 127 K (+9.40 %)
May 11 2004	CAQ	VIA Pharmaceutical ...	NICHOL F RICHARD PHD	Director	Option Exercise	A	5.50	18,000	99,000	18,000
May 11 2004	CAQ	VIA Pharmaceutical ...	NICHOL F RICHARD PHD	Director	Option Exercise	A	5.50	24,000	132,000	24,000
May 11 2004	CAQ	VIA Pharmaceutical ...	NICHOL F RICHARD PHD	Director	Buy	P	5.50	1,000	5,500	1,000	0 to 1,000
May 11 2004	CAQ	VIA Pharmaceutical ...	MERRIMAN RONALD	Director	Option Exercise	A	5.50	15,000	82,500	15,000
May 11 2004	CAQ	VIA Pharmaceutical ...	MERRIMAN RONALD	Director	Option Exercise	A	5.50	24,000	132,000	24,000

Page: 1 2 next >